Post-earnings recap
Reported
Thu, Feb 11, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
63%
DexCom reported an EPS of $0.91, slightly missing expectations, but the stock rose by 2.69%. This increase may reflect investor optimism despite the EPS miss, as the market often reacts positively to overall performance trends. Without detailed commentary from management, it’s challenging to assess future strategies or expectations.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.91 | N/A | -0.22% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—